Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalin

Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalin

Bruce Parsons, Birol Emir, Andrew Clair Pfizer, New York, NY, USA Background: Pregabalin is an α2δ ligand indicated in the USA for treatment of a number of chronic pain conditions, including diabetic peripheral neuropathy, postherpetic neuralgia, pain associated with spinal cord...

Full description

Bibliographic Details
Main Authors: Parsons B, Emir B, Clair A
Format: Article
Language:English
Published: Dove Medical Press 2015-06-01
Series:Journal of Pain Research
Online Access:http://www.dovepress.com/temporal-analysis-of-pain-responders-and-common-adverse-events-when-do-peer-reviewed-article-JPR

Internet

http://www.dovepress.com/temporal-analysis-of-pain-responders-and-common-adverse-events-when-do-peer-reviewed-article-JPR

Similar Items